Autopsy report · NCT02205476

A Phase 2 Extension Study To Enroll Subjects Who Were Enrolled In B5301001 Study

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“B5301001 study did not meet its predefined efficacy endpoints, the long term follow up study B5301012 was terminated in 1/6/2015. No safety concerns identified.”

The sponsor’s own words in the registry.

Life of this trial

Registered 5 months before it started.
Ran for about 1 month before it stopped.
10 participants enrolled.
Results were posted on the registry 1 year after it ended.

Vital statistics

Status: Terminated
Phase: Phase 2
Sponsor: Pfizer
Sponsor type: Industry
Conditions: Hypertrophic Scars Resulting From Prior Breast Scar Revision Surgery
Interventions: PF-06473871; PF-06473871
Participants: 10
Sites: 5
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.